What is your preferred approach to therapy in transplant ineligible multiple myeloma initially treated with CyBorD owing to acute renal failure, after achieving a VGPR (+IFE alone) with continued mild-moderate renal impairment?

After completion of initial treatment, our practice is to offer patients maintenance therapy with Revlimid based on the meta-analysis of Revlimid maintenance done in patients following autologous stem cell transplant. This includes patients who have not had lenalidomide upfront. Using maintenance le...